|
Volumn 59, Issue 2 Suppl B, 2007, Pages
|
Diabetic multivessel disease: stenting vs. coronary artery bypass grafting.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTITHROMBOCYTIC AGENT;
PACLITAXEL;
RAPAMYCIN;
CLINICAL TRIAL;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY DISEASE;
CORONARY ARTERY OBSTRUCTION;
DIABETES MELLITUS;
DRUG ELUTING STENT;
HUMAN;
PATHOLOGY;
REVIEW;
RISK FACTOR;
STENT;
CLINICAL TRIALS AS TOPIC;
CORONARY ARTERY BYPASS;
CORONARY ARTERY DISEASE;
CORONARY STENOSIS;
DIABETES COMPLICATIONS;
DRUG-ELUTING STENTS;
HUMANS;
PACLITAXEL;
PLATELET AGGREGATION INHIBITORS;
RISK FACTORS;
SIROLIMUS;
STENTS;
|
EID: 63249104709
PISSN: 00194832
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (1)
|
References (76)
|